Inhaled bronchodilators for acute chest syndrome in people with sickle cell disease

JM Knight-Madden… - Cochrane Database of …, 2022 - cochranelibrary.com
Cochrane Database of Systematic Reviews, 2022cochranelibrary.com
Background Bronchodilators are used to treat bronchial hyper‐responsiveness in asthma.
Bronchial hyper‐responsiveness may be a component of acute chest syndrome in people
with sickle cell disease. Therefore, bronchodilators may be useful in the treatment of acute
chest syndrome. This is an update of a previously published Cochrane Review. Objectives
The aim of the review is to determine whether the use of inhaled, short‐acting
bronchodilators for acute chest syndrome reduces morbidity and mortality in people with …
Background
Bronchodilators are used to treat bronchial hyper‐responsiveness in asthma. Bronchial hyper‐responsiveness may be a component of acute chest syndrome in people with sickle cell disease. Therefore, bronchodilators may be useful in the treatment of acute chest syndrome. This is an update of a previously published Cochrane Review.
Objectives
The aim of the review is to determine whether the use of inhaled, short‐acting bronchodilators for acute chest syndrome reduces morbidity and mortality in people with sickle cell disease and to assess whether this treatment causes adverse effects.
cochranelibrary.com
以上显示的是最相近的搜索结果。 查看全部搜索结果